NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $324,582 | -4.4% | 3,187 | -5.3% | 0.06% | +12.5% |
Q2 2023 | $339,618 | -6.2% | 3,366 | -14.5% | 0.06% | -13.8% |
Q1 2023 | $362,071 | -8.1% | 3,936 | -9.4% | 0.06% | -8.5% |
Q4 2022 | $393,997 | +26.7% | 4,343 | +6.1% | 0.07% | +9.2% |
Q3 2022 | $311,000 | -28.7% | 4,093 | -20.6% | 0.06% | -27.8% |
Q2 2022 | $436,000 | -3.8% | 5,158 | 0.0% | 0.09% | +15.4% |
Q1 2022 | $453,000 | -4.2% | 5,158 | -4.6% | 0.08% | -6.0% |
Q4 2021 | $473,000 | +1.1% | 5,404 | -5.5% | 0.08% | +10.7% |
Q3 2021 | $468,000 | -12.5% | 5,719 | -2.6% | 0.08% | -11.8% |
Q2 2021 | $535,000 | +4.3% | 5,869 | 0.0% | 0.08% | -5.6% |
Q1 2021 | $513,000 | +0.4% | 5,869 | +8.5% | 0.09% | +13.9% |
Q4 2020 | $511,000 | -1.0% | 5,407 | -8.9% | 0.08% | -21.0% |
Q3 2020 | $516,000 | -0.4% | 5,934 | +0.0% | 0.10% | -5.7% |
Q2 2020 | $518,000 | +7.2% | 5,933 | +1.3% | 0.11% | -13.1% |
Q1 2020 | $483,000 | -1.6% | 5,855 | +12.9% | 0.12% | +15.1% |
Q4 2019 | $491,000 | -5.2% | 5,188 | -13.0% | 0.11% | -3.6% |
Q3 2019 | $518,000 | +14.1% | 5,960 | +20.0% | 0.11% | +14.6% |
Q2 2019 | $454,000 | -6.8% | 4,968 | -1.9% | 0.10% | -25.6% |
Q1 2019 | $487,000 | +12.0% | 5,066 | 0.0% | 0.13% | +3.2% |
Q4 2018 | $435,000 | -5.6% | 5,066 | -5.3% | 0.12% | +9.6% |
Q3 2018 | $461,000 | +5.3% | 5,352 | -7.8% | 0.11% | -3.4% |
Q2 2018 | $438,000 | 0.0% | 5,802 | +7.1% | 0.12% | -1.7% |
Q1 2018 | $438,000 | -3.9% | 5,417 | -0.4% | 0.12% | +0.8% |
Q4 2017 | $456,000 | -14.1% | 5,437 | -12.2% | 0.12% | -17.4% |
Q3 2017 | $531,000 | +9.9% | 6,191 | +6.9% | 0.14% | +5.1% |
Q2 2017 | $483,000 | +22.0% | 5,791 | +8.7% | 0.14% | +20.2% |
Q1 2017 | $396,000 | +2.1% | 5,329 | 0.0% | 0.11% | -6.6% |
Q4 2016 | $388,000 | +9.3% | 5,329 | +18.7% | 0.12% | +1.7% |
Q3 2016 | $355,000 | -0.8% | 4,490 | +3.5% | 0.12% | -4.0% |
Q2 2016 | $358,000 | -50.6% | 4,340 | -56.6% | 0.12% | -60.9% |
Q1 2016 | $724,000 | -7.4% | 9,991 | +9.9% | 0.32% | -7.0% |
Q4 2015 | $782,000 | -6.5% | 9,091 | 0.0% | 0.34% | -21.5% |
Q3 2015 | $836,000 | +46.7% | 9,091 | +56.7% | 0.44% | +41.7% |
Q2 2015 | $570,000 | -10.9% | 5,800 | -10.6% | 0.31% | -6.9% |
Q1 2015 | $640,000 | – | 6,488 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |